ArticleCellular and molecular life sciences : CMLS2020

Thalidomide targets EGFL6 to inhibit EGFL6/PAX6 axis-driven angiogenesis in small bowel vascular malformation.

Chao-Tao Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.